<DOC>
	<DOC>NCT00679653</DOC>
	<brief_summary>To study the effect of sibutramine treatment on weight reduction and blood pressure improvement in three groups with antihypertensive therapy whose blood pressure was not adequately controlled with antihypertensive combination treatment.</brief_summary>
	<brief_title>Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives</brief_title>
	<detailed_description />
	<mesh_term>Trandolapril</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<mesh_term>Sibutramine</mesh_term>
	<criteria>Treated essential hypertension. Obesity: BMI 2735 kg/m2 Secondary hypertension. Stage 3 hypertension. Secondary obesity; BMI &gt; 35kg/m2. CAD; MI within past 6 months; NYHA stage 3 or 4 heart failure; tachyarrhythmia/atrial fibrillation; myocarditis. Kidney failure. Liver failure. Hyperthyroidism. Unstable DM. Carcinoma. Severe chronic infectious disease. Alcohol or drug abuse. Pregnancy. Epilepsy. Psychosis or treatment with antidepressants or major tranquilizers</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>